PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEdoxaban
Savaysa, Lixiana(edoxaban)
Lixiana, Roteas, Savaysa (edoxaban) is a small molecule pharmaceutical. Edoxaban was first approved as Savaysa on 2015-01-08. It is used to treat pulmonary embolism and venous thrombosis in the USA. It has been approved in Europe to treat stroke and venous thromboembolism. The pharmaceutical is active against coagulation factor X.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
nervous system diseasesD009422
cardiovascular diseasesD002318
Trade Name
FDA
EMA
Savaysa
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Edoxaban tosylate
Tradename
Company
Number
Date
Products
SAVAYSADaiichi PharmaceuticalN-206316 RX2015-01-08
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
savaysaNew Drug Application2024-02-06
Indications
FDA
EMA
Agency Specific
FDA
EMA
Expiration
Code
EDOXABAN TOSYLATE, SAVAYSA, DAIICHI SANKYO INC
2026-10-18M-14
Patent Expiration
Patent
Expires
Flag
FDA Information
Edoxaban Tosylate, Savaysa, Daiichi Sankyo Inc
91495322028-03-28DP
73652052027-04-18DP
ATC Codes
B: Blood and blood forming organ drugs
B01: Antithrombotic agents
B01A: Antithrombotic agents
B01AF: Direct factor xa inhibitors
B01AF03: Edoxaban
HCPCS
No data
Clinical
Clinical Trials
190 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.03641023
ThrombosisD013927153110
EmbolismD0046171416
StrokeD020521EFO_0000712I63.912115
Coronary artery diseaseD003324I25.11134
HemorrhageD006470MP_0001914R58112
Coronary diseaseD00332722
Myocardial ischemiaD017202EFO_1001375I20-I2522
Myocardial infarctionD009203EFO_0000612I2111
Acute coronary syndromeD054058EFO_000567211
Show 6 more
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Replacement arthroplasty hipD01964422
Peripheral arterial diseaseD058729EFO_000426511
Peripheral vascular diseasesD016491EFO_0003875I73.911
Embolism and thrombosisD01676911
Replacement arthroplasty kneeD01964511
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
IschemiaD007511EFO_000055611
Cerebral infarctionD002544I6311
Heart failureD006333EFO_0003144I5011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEdoxaban
INNedoxaban
Description
Edoxaban is a monocarboxylic acid amide that is used (as its tosylate monohydrate) for the treatment of deep vein thrombosis and pulmonary embolism. It has a role as an anticoagulant, an EC 3.4.21.6 (coagulation factor Xa) inhibitor and a platelet aggregation inhibitor. It is a monocarboxylic acid amide, a chloropyridine, a thiazolopyridine and a tertiary amino compound. It is a conjugate base of an edoxaban(1+).
Classification
Small molecule
Drug classantithrombotics, blood coagulation factor XA inhibitors
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1
Identifiers
PDB
CAS-ID480449-70-5
RxCUI
ChEMBL IDCHEMBL1269025
ChEBI ID85973
PubChem CID10280735
DrugBankDB09075
UNII IDNDU3J18APO (ChemIDplus, GSRS)
Target
Agency Approved
F10
F10
Organism
Homo sapiens
Gene name
F10
Gene synonyms
NCBI Gene ID
Protein name
coagulation factor X
Protein synonyms
factor X, factor Xa, prothrombinase, Stuart factor, Stuart-Prower factor
Uniprot ID
Mouse ortholog
F10 (14058)
coagulation factor X (Q99L32)
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 8,405 documents
View more details
Safety
Black-box Warning
Black-box warning for: Savaysa
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
8,276 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use